Niclosamide inhibits the phosphorylation of the ERK, Mnk1, and eIF4E signaling pathways, and it also inhibits the proliferation of and induces apoptosis in chronic myeloid leukemia cells [37]. Here, MKNK1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.